Tweet
From London on 7 May 2009
"detailed report on the use of Tamiflu and Relenza as relates to:
1- shelf life being extended from 5 to 7 years,
2- administering to children under one year of age,
3- use during pregnancy/ lactation...overall data suggest use of tamiflu in pregnant or breast-feeding women outweighs risk in context of novel influenza in a pandemic situation..."
at link:
http:/www.emea.europa.eu/humandocs/PDF's/EPAR/tamiflu/28766209en.pdf
"detailed report on the use of Tamiflu and Relenza as relates to:
1- shelf life being extended from 5 to 7 years,
2- administering to children under one year of age,
3- use during pregnancy/ lactation...overall data suggest use of tamiflu in pregnant or breast-feeding women outweighs risk in context of novel influenza in a pandemic situation..."
at link:
http:/www.emea.europa.eu/humandocs/PDF's/EPAR/tamiflu/28766209en.pdf